(−)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury

Cheng Fu Chang, Jing Huei Lai, John Chung Che Wu, Nigel H. Greig, Robert E. Becker, Yu Luo, Yen Hua Chen, Shuo Jhen Kang, Yung Hsiao Chiang, Kai Yun Chen

研究成果: 雜誌貢獻文章

9 引文 (Scopus)

摘要

Stroke commonly leads to adult disability and death worldwide. Its major symptoms are spastic hemiplegia and discordant motion, consequent to neuronal cell death induced by brain vessel occlusion. Acetylcholinesterase (AChE) is upregulated and allied with inflammation and apoptosis after stroke. Recent studies suggest that AChE inhibition ameliorates ischemia-reperfusion injury and has neuroprotective properties. (−)-Phenserine, a reversible AChE inhibitor, has a broad range of actions independent of its AChE properties, including neuroprotective ones. However, its protective effects and detailed mechanism of action in the rat middle cerebral artery occlusion model (MCAO) remain to be elucidated. This study investigated the therapeutic effects of (−)-phenserine for stroke in the rat focal cerebral ischemia model and oxygen-glucose deprivation/reperfusion (OGD/RP) damage model in SH-SY5Y neuronal cultures. (−)-Phenserine mitigated OGD/PR-induced SH-SY5Y cell death, providing an inverted U-shaped dose-response relationship between concentration and survival. In MCAO challenged rats, (−)-phenserine reduced infarction volume, cell death and improved body asymmetry, a behavioral measure of stoke impact. In both cellular and animal studies, (−)-phenserine elevated brain-derived neurotrophic factor (BDNF) and B-cell lymphoma 2 (Bcl-2) levels, and decreased activated-caspase 3, amyloid precursor protein (APP) and glial fibrillary acidic protein (GFAP) expression, potentially mediated through the ERK-1/2 signaling pathway. These actions mitigated neuronal apoptosis in the stroke penumbra, and decreased matrix metallopeptidase-9 (MMP-9) expression. In synopsis, (−)-phenserine significantly reduced neuronal damage induced by ischemia/reperfusion injury in a rat model of MCAO and cellular model of OGD/RP, demonstrating that its anti-apoptotic/neuroprotective/neurotrophic cholinergic and non-cholinergic properties warrant further evaluation in conditions of brain injury.
原文英語
頁(從 - 到)118-128
頁數11
期刊Brain Research
1677
DOIs
出版狀態已發佈 - 十二月 15 2017

指紋

Reperfusion Injury
Apoptosis
Middle Cerebral Artery Infarction
Acetylcholinesterase
Stroke
Cell Death
Oxygen
Glucose
Hemiplegia
Amyloid beta-Protein Precursor
Glial Fibrillary Acidic Protein
Cholinesterase Inhibitors
Brain-Derived Neurotrophic Factor
Metalloproteases
B-Cell Lymphoma
Therapeutic Uses
Brain Ischemia
Caspase 3
Brain Injuries
Infarction

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

引用此文

(−)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury. / Chang, Cheng Fu; Lai, Jing Huei; Wu, John Chung Che; Greig, Nigel H.; Becker, Robert E.; Luo, Yu; Chen, Yen Hua; Kang, Shuo Jhen; Chiang, Yung Hsiao; Chen, Kai Yun.

於: Brain Research, 卷 1677, 15.12.2017, p. 118-128.

研究成果: 雜誌貢獻文章

Chang, Cheng Fu ; Lai, Jing Huei ; Wu, John Chung Che ; Greig, Nigel H. ; Becker, Robert E. ; Luo, Yu ; Chen, Yen Hua ; Kang, Shuo Jhen ; Chiang, Yung Hsiao ; Chen, Kai Yun. / (−)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury. 於: Brain Research. 2017 ; 卷 1677. 頁 118-128.
@article{d5712854b25c4d6fa7e21dc58d9bce40,
title = "(−)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury",
abstract = "Stroke commonly leads to adult disability and death worldwide. Its major symptoms are spastic hemiplegia and discordant motion, consequent to neuronal cell death induced by brain vessel occlusion. Acetylcholinesterase (AChE) is upregulated and allied with inflammation and apoptosis after stroke. Recent studies suggest that AChE inhibition ameliorates ischemia-reperfusion injury and has neuroprotective properties. (−)-Phenserine, a reversible AChE inhibitor, has a broad range of actions independent of its AChE properties, including neuroprotective ones. However, its protective effects and detailed mechanism of action in the rat middle cerebral artery occlusion model (MCAO) remain to be elucidated. This study investigated the therapeutic effects of (−)-phenserine for stroke in the rat focal cerebral ischemia model and oxygen-glucose deprivation/reperfusion (OGD/RP) damage model in SH-SY5Y neuronal cultures. (−)-Phenserine mitigated OGD/PR-induced SH-SY5Y cell death, providing an inverted U-shaped dose-response relationship between concentration and survival. In MCAO challenged rats, (−)-phenserine reduced infarction volume, cell death and improved body asymmetry, a behavioral measure of stoke impact. In both cellular and animal studies, (−)-phenserine elevated brain-derived neurotrophic factor (BDNF) and B-cell lymphoma 2 (Bcl-2) levels, and decreased activated-caspase 3, amyloid precursor protein (APP) and glial fibrillary acidic protein (GFAP) expression, potentially mediated through the ERK-1/2 signaling pathway. These actions mitigated neuronal apoptosis in the stroke penumbra, and decreased matrix metallopeptidase-9 (MMP-9) expression. In synopsis, (−)-phenserine significantly reduced neuronal damage induced by ischemia/reperfusion injury in a rat model of MCAO and cellular model of OGD/RP, demonstrating that its anti-apoptotic/neuroprotective/neurotrophic cholinergic and non-cholinergic properties warrant further evaluation in conditions of brain injury.",
keywords = "(−)-Phenserine, Activated-caspase 3, Amyloid precursor protein (APP), B-cell lymphoma 2 (Bcl-2) expression, Brain-derived neurotrophic factor (BDNF), ERK-1/2 signaling pathway, Glial fibrillary acidic protein (GFAP), Ischemia/reperfusion injury, Metallopeptidase-9 (MMP-9), Middle cerebral artery occlusion (MCAO), Stroke",
author = "Chang, {Cheng Fu} and Lai, {Jing Huei} and Wu, {John Chung Che} and Greig, {Nigel H.} and Becker, {Robert E.} and Yu Luo and Chen, {Yen Hua} and Kang, {Shuo Jhen} and Chiang, {Yung Hsiao} and Chen, {Kai Yun}",
year = "2017",
month = "12",
day = "15",
doi = "10.1016/j.brainres.2017.09.015",
language = "English",
volume = "1677",
pages = "118--128",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - (−)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury

AU - Chang, Cheng Fu

AU - Lai, Jing Huei

AU - Wu, John Chung Che

AU - Greig, Nigel H.

AU - Becker, Robert E.

AU - Luo, Yu

AU - Chen, Yen Hua

AU - Kang, Shuo Jhen

AU - Chiang, Yung Hsiao

AU - Chen, Kai Yun

PY - 2017/12/15

Y1 - 2017/12/15

N2 - Stroke commonly leads to adult disability and death worldwide. Its major symptoms are spastic hemiplegia and discordant motion, consequent to neuronal cell death induced by brain vessel occlusion. Acetylcholinesterase (AChE) is upregulated and allied with inflammation and apoptosis after stroke. Recent studies suggest that AChE inhibition ameliorates ischemia-reperfusion injury and has neuroprotective properties. (−)-Phenserine, a reversible AChE inhibitor, has a broad range of actions independent of its AChE properties, including neuroprotective ones. However, its protective effects and detailed mechanism of action in the rat middle cerebral artery occlusion model (MCAO) remain to be elucidated. This study investigated the therapeutic effects of (−)-phenserine for stroke in the rat focal cerebral ischemia model and oxygen-glucose deprivation/reperfusion (OGD/RP) damage model in SH-SY5Y neuronal cultures. (−)-Phenserine mitigated OGD/PR-induced SH-SY5Y cell death, providing an inverted U-shaped dose-response relationship between concentration and survival. In MCAO challenged rats, (−)-phenserine reduced infarction volume, cell death and improved body asymmetry, a behavioral measure of stoke impact. In both cellular and animal studies, (−)-phenserine elevated brain-derived neurotrophic factor (BDNF) and B-cell lymphoma 2 (Bcl-2) levels, and decreased activated-caspase 3, amyloid precursor protein (APP) and glial fibrillary acidic protein (GFAP) expression, potentially mediated through the ERK-1/2 signaling pathway. These actions mitigated neuronal apoptosis in the stroke penumbra, and decreased matrix metallopeptidase-9 (MMP-9) expression. In synopsis, (−)-phenserine significantly reduced neuronal damage induced by ischemia/reperfusion injury in a rat model of MCAO and cellular model of OGD/RP, demonstrating that its anti-apoptotic/neuroprotective/neurotrophic cholinergic and non-cholinergic properties warrant further evaluation in conditions of brain injury.

AB - Stroke commonly leads to adult disability and death worldwide. Its major symptoms are spastic hemiplegia and discordant motion, consequent to neuronal cell death induced by brain vessel occlusion. Acetylcholinesterase (AChE) is upregulated and allied with inflammation and apoptosis after stroke. Recent studies suggest that AChE inhibition ameliorates ischemia-reperfusion injury and has neuroprotective properties. (−)-Phenserine, a reversible AChE inhibitor, has a broad range of actions independent of its AChE properties, including neuroprotective ones. However, its protective effects and detailed mechanism of action in the rat middle cerebral artery occlusion model (MCAO) remain to be elucidated. This study investigated the therapeutic effects of (−)-phenserine for stroke in the rat focal cerebral ischemia model and oxygen-glucose deprivation/reperfusion (OGD/RP) damage model in SH-SY5Y neuronal cultures. (−)-Phenserine mitigated OGD/PR-induced SH-SY5Y cell death, providing an inverted U-shaped dose-response relationship between concentration and survival. In MCAO challenged rats, (−)-phenserine reduced infarction volume, cell death and improved body asymmetry, a behavioral measure of stoke impact. In both cellular and animal studies, (−)-phenserine elevated brain-derived neurotrophic factor (BDNF) and B-cell lymphoma 2 (Bcl-2) levels, and decreased activated-caspase 3, amyloid precursor protein (APP) and glial fibrillary acidic protein (GFAP) expression, potentially mediated through the ERK-1/2 signaling pathway. These actions mitigated neuronal apoptosis in the stroke penumbra, and decreased matrix metallopeptidase-9 (MMP-9) expression. In synopsis, (−)-phenserine significantly reduced neuronal damage induced by ischemia/reperfusion injury in a rat model of MCAO and cellular model of OGD/RP, demonstrating that its anti-apoptotic/neuroprotective/neurotrophic cholinergic and non-cholinergic properties warrant further evaluation in conditions of brain injury.

KW - (−)-Phenserine

KW - Activated-caspase 3

KW - Amyloid precursor protein (APP)

KW - B-cell lymphoma 2 (Bcl-2) expression

KW - Brain-derived neurotrophic factor (BDNF)

KW - ERK-1/2 signaling pathway

KW - Glial fibrillary acidic protein (GFAP)

KW - Ischemia/reperfusion injury

KW - Metallopeptidase-9 (MMP-9)

KW - Middle cerebral artery occlusion (MCAO)

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85030486032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030486032&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2017.09.015

DO - 10.1016/j.brainres.2017.09.015

M3 - Article

AN - SCOPUS:85030486032

VL - 1677

SP - 118

EP - 128

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -